Investor Dossier
Boehringer Ingelheim Venture Fund
active
Typeinvestor
Location—
Portfolio (3 investments)
ImCheck Therapeutics
Series C · Jun 2022
€96.0M
DiogenX
Series A · May 2023
€34.0M
DiogenX
Series A · May 2023
€27.5M
Investor Dossier
Series C · Jun 2022
€96.0M
Series A · May 2023
€34.0M
Series A · May 2023
€27.5M